BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31222643)

  • 1. Change in Skeletal Muscle Following Resection of Stage I-III Colorectal Cancer is Predictive of Poor Survival: A Cohort Study.
    Hopkins JJ; Reif R; Bigam D; Baracos VE; Eurich DT; Sawyer MM
    World J Surg; 2019 Oct; 43(10):2518-2526. PubMed ID: 31222643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Muscle and Adipose Tissue on Long-term Survival in Patients With Stage I to III Colorectal Cancer.
    Hopkins JJ; Reif RL; Bigam DL; Baracos VE; Eurich DT; Sawyer MB
    Dis Colon Rectum; 2019 May; 62(5):549-560. PubMed ID: 30789442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body composition measured by computed tomography is associated with colorectal cancer survival, also in early-stage disease.
    Shirdel M; Andersson F; Myte R; Axelsson J; RutegÄrd M; Blomqvist L; Riklund K; van Guelpen B; Palmqvist R; Gylling B
    Acta Oncol; 2020 Jul; 59(7):799-808. PubMed ID: 32228271
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of Muscle and Adiposity Measured by Computed Tomography With Survival in Patients With Nonmetastatic Breast Cancer.
    Caan BJ; Cespedes Feliciano EM; Prado CM; Alexeeff S; Kroenke CH; Bradshaw P; Quesenberry CP; Weltzien EK; Castillo AL; Olobatuyi TA; Chen WY
    JAMA Oncol; 2018 Jun; 4(6):798-804. PubMed ID: 29621380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer: Results From the C SCANS Study.
    Feliciano EMC; Kroenke CH; Meyerhardt JA; Prado CM; Bradshaw PT; Kwan ML; Xiao J; Alexeeff S; Corley D; Weltzien E; Castillo AL; Caan BJ
    JAMA Oncol; 2017 Dec; 3(12):e172319. PubMed ID: 28796857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer.
    Miyamoto Y; Baba Y; Sakamoto Y; Ohuchi M; Tokunaga R; Kurashige J; Hiyoshi Y; Iwagami S; Yoshida N; Yoshida M; Watanabe M; Baba H
    Ann Surg Oncol; 2015 Aug; 22(8):2663-8. PubMed ID: 25564158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of sarcopenia in patients with colorectal liver metastases undergoing hepatic resection.
    Liu YW; Lu CC; Chang CD; Lee KC; Chen HH; Yeh WS; Hu WH; Tsai KL; Yeh CH; Wee SY; Yin SM; Wang CC; Hung CH
    Sci Rep; 2020 Apr; 10(1):6459. PubMed ID: 32296122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for low muscularity in colorectal cancer patients: a valid, clinic-friendly approach that predicts mortality.
    Cespedes Feliciano EM; Avrutin E; Caan BJ; Boroian A; Mourtzakis M
    J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):898-908. PubMed ID: 30066490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle radiodensity and mortality in patients with colorectal cancer.
    Kroenke CH; Prado CM; Meyerhardt JA; Weltzien EK; Xiao J; Cespedes Feliciano EM; Caan BJ
    Cancer; 2018 Jul; 124(14):3008-3015. PubMed ID: 29797673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The deterioration of muscle mass and radiodensity is prognostic of poor survival in stage I-III colorectal cancer: a population-based cohort study (C-SCANS).
    Brown JC; Caan BJ; Meyerhardt JA; Weltzien E; Xiao J; Cespedes Feliciano EM; Kroenke CH; Castillo A; Kwan ML; Prado CM
    J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):664-672. PubMed ID: 29766660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial.
    Kurk SA; Peeters PHM; Dorresteijn B; de Jong PA; Jourdan M; Creemers GM; Erdkamp FLG; de Jongh FE; Kint PAM; Poppema BJ; Radema SA; Simkens LHJ; Tanis BC; Tjin-A-Ton MLR; Van Der Velden A; Punt CJA; Koopman M; May AM
    Cancer Med; 2020 Feb; 9(3):1033-1043. PubMed ID: 31850687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of preoperative and postoperative sarcopenia on oncological outcomes in non-metastatic colorectal cancer.
    Lee J; Cho JR; Kim DW; Yang IJ; Suh JW; Oh HK; Kang SB
    Colorectal Dis; 2023 Apr; 25(4):775-786. PubMed ID: 36461667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Impact of Muscle Quantity and Quality in Colorectal Cancer Patients: A Propensity Score Matching Analysis.
    Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Yin C; Narumi A; Omura Y; Ide S; Kitajima T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Kobayashi M; Araki T; McMillan DC; Miki C; Kusunoki M
    JPEN J Parenter Enteral Nutr; 2018 Nov; 42(8):1322-1333. PubMed ID: 29761898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity is Associated with Longer Survival Independent of Sarcopenia and Myosteatosis in Metastatic and/or Castrate-Resistant Prostate Cancer.
    Xu MC; Huelster HL; Hatcher JB; Avulova S; Stocks BT; Glaser ZA; Moses KA; Silver HJ
    J Urol; 2021 Mar; 205(3):800-805. PubMed ID: 33080148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical performance has a strong association with poor surgical outcome in older patients with colorectal cancer.
    Souwer ET; Moos SI; van Rooden CJ; Bijlsma AY; Bastiaannet E; Steup WH; Dekker JWT; Fiocco M; van den Bos F; Portielje JE
    Eur J Surg Oncol; 2020 Mar; 46(3):462-469. PubMed ID: 31899045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle radiodensity loss during cancer therapy is predictive for poor survival in advanced endometrial cancer.
    Lee J; Lin JB; Wu MH; Jan YT; Chang CL; Huang CY; Sun FJ; Chen YJ
    J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):814-826. PubMed ID: 31094101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of medical and demographic characteristics with sarcopenia and low muscle radiodensity in patients with nonmetastatic colorectal cancer.
    Xiao J; Caan BJ; Cespedes Feliciano EM; Meyerhardt JA; Kroenke CH; Baracos VE; Weltzien E; Kwan ML; Alexeeff SE; Castillo AL; Prado CM
    Am J Clin Nutr; 2019 Mar; 109(3):615-625. PubMed ID: 30850836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Visceral Adiposity as Well as Sarcopenic Factors on Outcomes in Patients Undergoing Liver Resection for Colorectal Liver Metastases.
    Kobayashi A; Kaido T; Hamaguchi Y; Okumura S; Shirai H; Kamo N; Yagi S; Taura K; Okajima H; Uemoto S
    World J Surg; 2018 Apr; 42(4):1180-1191. PubMed ID: 28936708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of neoadjuvant chemotherapy on skeletal muscle depletion and preoperative sarcopenia in patients with resectable colorectal liver metastases.
    Eriksson S; Nilsson JH; Strandberg Holka P; Eberhard J; Keussen I; Sturesson C
    HPB (Oxford); 2017 Apr; 19(4):331-337. PubMed ID: 28089364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Explaining the Obesity Paradox: The Association between Body Composition and Colorectal Cancer Survival (C-SCANS Study).
    Caan BJ; Meyerhardt JA; Kroenke CH; Alexeeff S; Xiao J; Weltzien E; Feliciano EC; Castillo AL; Quesenberry CP; Kwan ML; Prado CM
    Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1008-1015. PubMed ID: 28506965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.